-+ 0.00%
-+ 0.00%
-+ 0.00%

Palvella Therapeutics names pediatric dermatologist James Treat chief medical officer

PUBT·09/09/2026 11:32:50
Listen to the news
Palvella Therapeutics names pediatric dermatologist James Treat chief medical officer
  • Palvella Therapeutics appointed James R. Treat as chief medical officer, effective Dec. 21, 2026.
  • Treat most recently served as a pediatric dermatologist at Children’s Hospital of Philadelphia.
  • He was associate program director of CHOP’s Pediatric Dermatology Fellowship Program, following more than 12 years as program director.
  • Treat has been a QTORIN rapamycin trial investigator, including as a site investigator for the Phase 3 SELVA study.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090730PRIMZONEFULLFEED9823692) on September 09, 2026, and is solely responsible for the information contained therein.